Inflammatory pathway genes belong to major targets of persistent organic pollutants in adipose cells

Environmental Health Perspectives

Volumn 120, Issue 4, 2012, Pages 508-514

  Kim, Min Ji ^a   Pelloux, Véronique ^b,c   Guyot, Erwan ^a   Tordjman, Joan ^b,c   Bui, Linh Chi ^a   Chevallier, Aline ^a   Forest, Claude ^a   Benelli, Chantal ^a   Clément, Karine ^b,c   Barouki, Robert ^a,d  

^a INSERM   (France)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c Institute of Cardiometabolism and Nutrition   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Adipocytes; Adipose tissue; Inflammation; Obesity; PCB; Persistent organic pollutants; TCDD

Indexed keywords

2, 2', 4, 4', 5, 5' HEXACHLOROBIPHENYL; 2, 3, 7, 8 TETRACHLORODIBENZO PARA DIOXIN; 3, 3', 4, 4', 5 PENTACHLOROBIPHENYL; AROMATIC HYDROCARBON RECEPTOR; CYTOKINE; MESSENGER RNA; POLYCHLORINATED BIPHENYL; UNCLASSIFIED DRUG;

ADIPOSE TISSUE CELL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KNOCKOUT MOUSE; MACROPHAGE; MALE; METABOLIC DISORDER; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PERSISTENT ORGANIC POLLUTANT; POLLUTANT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; BENZOFLAVONES; BODY WEIGHT; CELL DIFFERENTIATION; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; MICE; MICE, KNOCKOUT; MULTIPOTENT STEM CELLS; OBESITY; POLYCHLORINATED BIPHENYLS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRACHLORODIBENZODIOXIN; WEIGHT GAIN;

MUS; RODENTIA;

EID: 84859336968     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1104282     Document Type: Article

References (44)

1. Airaksinen R, Rantakokko P, Eriksson JG, Blomstedt P, Kajantie E, Kiviranta H. 2011. Association between type 2 diabetes and exposure to persistent organic pollutants. Diabetes Care 34(9):1972-1979.
2. Alexander DL, Ganem LG, Fernandez-Salguero P, Gonzalez F, Jefcoate CR. 1998. Aryl-hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis. J Cell Sci 111(22):3311-3322.
3. Alonso-Magdalena P, Quesada I, Nadal A. 2011. Endocrine disruptors in the etiology of type 2 diabetes mellitus. Nat Rev Endocrinol 7(6):346-353.
4. Arsenescu V, Arsenescu RI, King V, Swanson H, Cassis LA. 2008. Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflammatory adipokines and promotes obesity and atherosclerosis. Environ Health Perspect 116:761-768.
5. Barouki R, Coumoul X, Fernandez-Salguero PM. 2007. The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett 581(19):3608-3615.
6. Brake DK, Smith EO, Mersmann H, Smith CW, Robker RL. 2006. ICAM-1 expression in adipose tissue: effects of diet-induced obesity in mice. Am J Physiol Cell Physiol 291(6):C1232-C1239.
7. Cancello R, Tordjman J, Poitou C, Guilhem G, Bouillot JL, Hugol D, et al. 2006. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 55(6):1554-1561.
8. Chan SSY, Twigg SM, Firth SM, Baxter RC. 2005. Insulin-like growth factor binding protein-3 leads to insulin resistance in adipocytes. J Clin Endocrinol Metab 90(12):6588-6595.
9. Chapman DE, Schiller CM. 1985. Dose-related effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57BL/6J and DBA/2J mice. Toxicol Appl Pharmacol 78(1):147-157.
10. Dalmas E, Clément K, Guerre-Millo M. 2011. Defining macrophage phenotype and function in adipose tissue. Trends Immunol 32(7):307-314.
11. Denison MS, Pandini A, Nagy SR, Baldwin EP, Bonati L. 2002. Ligand binding and activation of the Ah receptor. Chem Biol Interact 141:3-24.
12. Emond C, Birnbaum LS, DeVito MJ. 2006. Use of a physiologically based pharmacokinetic model for rats to study the influence of body fat mass and induction of CYP1A2 on the pharmacokinetics of TCDD. Environ Health Perspect 114:1394-1400.
13. Fain JN. 2010. Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Mediators Inflamm 2010:513948; doi:10.1155/2010/513948 [Online 23 February 2010].
14. Fernandez-Salguero P, Pineau T, Hilbert DM, McPhail T, Lee SS, Kimura S, et al. 1995. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268(5211):722-726.
15. Goldberg RB. 2009. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 94(9):3171-3182.
16. Ha MH, Lee DH, Jacobs DR. 2007. Association between serum concentrations of persistent organic pollutants and self-reported cardiovascular disease prevalence: results from the National Health and Nutrition Examination Survey, 1999-2002. Environ Health Perspect 115:1204-1209.
17. Haarmann-Stemmann T, Bothe H, Abel J. 2009. Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways. Biochem Pharmacol 77(4):508-520.
18. Harvey AE, Lashinger LM, Hursting SD. 2011. The growing challenge of obesity and cancer: an inflammatory issue. Ann NY Acad Sci 1229:45-52.
19. Hsu H-F, Tsou T-C, Chao H-R, Kuo Y-T, Tsai F-Y, Yeh S-C. 2010. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on adipogenic differentiation and insulin-induced glucose uptake in 3T3-L1 cells. J Hazard Mater 182(1-3):649-655.
20. Kanehisa M, Goto S. 2000. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 28, 27-30.
21. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. 2011. KEGG for integration and interpretation of large-scale molecular datasets. Nucleic Acids Res 40:D109-D114; doi:10.1093/nar/gkr988 [Online 10 November 2011].
22. Khazen W, M'bika JP, Tomkiewicz C, Benelli C, Chany C, Achour A, et al. 2005. Expression of macrophage-selective markers in human and rodent adipocytes. FEBS Lett 579(25):5631-5634.
23. Kim M-J, Marchand P, Henegar C, Antignac J-P, Alili R, Poitou C, et al. 2010. Fate and complex pathogenic effects of dioxins and polychlorinated biphenyls in obese subjects before and after drastic weight loss. Environ Health Perspect 119:377-383.
24. Knerr S, Schrenk D. 2006. Carcinogenicity of "non-dioxinlike" polychlorinated biphenyls. Crit Rev Toxicol 36(9):663-694.
25. Lemoine S, Combes F, Servant N, Le Crom S. 2006. Goulphar: rapid access and expertise for standard two-color microarray normalization methods. BMC Bioinformatics 7:467; doi:10.1186/1471-2105-7-467 [Online 23 October 2006].
26. Li W, Vogel CFA, Fujiyoshi P, Matsumura F. 2008. Development of a human adipocyte model derived from human mesenchymal stem cells (hMSC) as a tool for toxicological studies on the action of TCDD. Biol Chem 389(2):169-177.
27. McLaughlin T, Deng A, Yee G, Lamendola C, Reaven G, Tsao PS, et al. 2010. Inflammation in subcutaneous adipose tissue: relationship to adipose cell size. Diabetologia 53(2):369-377.
28. Milbrath MO, Wenger Y, Chang CW, Emond C, Garabrant D, Gillespie BW, et al. 2009. Apparent half-lives of dioxins, furans, and polychlorinated biphenyls as a function of age, body fat, smoking status, and breast-feeding. Environ Health Perspect 117:417-425.
29. Nishiumi S, Yoshida M, Azuma T, Yoshida K-I, Ashida H. 2010. 2,3,7,8-Tetrachlorodibenzo-p-dioxin impairs an insulin signaling pathway through the induction of tumor necrosis factor-α in adipocytes. Toxicol Sci 115(2):482-491.
30. Palming J, Sjoholm K, Jernas M, Lystig TC, Gummesson A, Romeo S, et al. 2007. The expression of NAD(P)H:quinone oxidoreductase 1 is high in human adipose tissue, reduced by weight loss, and correlates with adiposity, insulin sensitivity, and markers of liver dysfunction. J Clin Endocrinol Metab 92(6):2346-2352.
31. Piaggi S, Novelli M, Martino L, Masini M, Raggi C, Orciuolo E, et al. 2007. Cell death and impairment of glucose-stimulated insulin secretion induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the β-cell line INS-1E. Toxicol Appl Pharmacol 220(3):333-340.
32. Prifti E, Zucker J-D, Clement K, Henegar C. 2008. FunNet: an integrative tool for exploring transcriptional interactions. Bioinformatics 24(22):2636-2638.
33. Puga A, Ma C, Marlowe JL. 2009. The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem Pharmacol 77(4):713-722.
34. Rodriguez AM, Elabd C, Amri EZ, Ailhaud G, Dani C. 2005a. The human adipose tissue is a source of multipotent stem cells. Biochimie 87(1):125-128.
35. Rodriguez AM, Pisani D, Dechesne CA, Turc-Carel C, Kurzenne JY, Wdziekonski B, et al. 2005b. Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J Exp Med 201(9):1397-1405.
36. Schlezinger JJ, Bernard PL, Haas A, Grandjean P, Weihe P, Sherr DH. 2010. Direct assessment of cumulative aryl hydrocarbon receptor agonist activity in sera from experimentally exposed mice and environmentally exposed humans. Environ Health Perspect 118:693-698.
37. Shimba S, Todoroki K, Aoyagi T, Tezuka M. 1998. Depletion of arylhydrocarbon receptor during adipose differentiation in 3T3-L1 cells. Biochem Biophys Res Commun 249(1):131-137.
38. Stienstra R, van Diepen JA, Tack CJ, Zaki MH, van de Veerdonk FL, Perera D, et al. 2011. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci USA 108(37):15324-15329.
39. Uemura H, Arisawa K, Hiyoshi M, Kitayama A, Takami H, Sawachika F, et al. 2009. Prevalence of metabolic syndrome associated with body burden levels of dioxin and related compounds among Japan's general population. Environ Health Perspect 117:568-573.
40. Varma V, Yao-Borengasser A, Bodles AM, Rasouli N, Phanavanh B, Nolen GT, et al. 2008. Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance. Diabetes 57(2):432-439.
41. Wang X, Santostefano MJ, DeVito MJ, Birnbaum LS. 2000. Extrapolation of a PBPK model for dioxins across dosage regimen, gender, strain, and species. Toxicol Sci 56(1):49-60.
42. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112(12):1796-1808.
43. Wen L, Christoph FAV, Fumio M. 2007. Studies on the cell treatment conditions to elicit lipolytic responses from 3T3-L1 adipocytes to TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Cell Biochem 102(2):389-402.
44. Zaragosi L-E, Ailhaud G, Dani C. 2006. Autocrine fibroblast growth factor 2 signaling is critical for self-renewal of human multipotent adipose-derived stem cells. Stem Cells 24(11):2412-2419.